2. Gene
  3. PGP - phosphoglycolate phosphatase Gene

PGP - phosphoglycolate phosphatase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Macaca fascicularis

基因 ID: 102115347 | 基因类型: protein coding

关于 PGP

PGP 基因产物(1)

mRNA Protein Name
XM_005590957.3 XP_005591014.1 glycerol-3-phosphate phosphatase
蛋白主名 其他名称

glycerol-3-phosphate phosphatase

相关产品

Approval
生物活性分子 (16)
目录号 产品名 作用方式
纯度 是否罕见病
HY-14275 Verapamil 99.96% 是
HY-A0064 Verapamil hydrochloride 99.98% 是
HY-10440 Vismodegib 99.97% 是
HY-N6972 Cepharanthine 99.87% 是
HY-W018791 Bifendate 99.92% 否
HY-17367 Atazanavir 99.86% 是
HY-B0777 Moxidectin Inhibitor 99.32% 是
HY-16397 Phenformin 99.72% 否
HY-17367A Atazanavir sulfate 99.68% 是
HY-145574 Iruplinalkib Inhibitor 99.62% 否
HY-B0168B Levomilnacipran hydrochloride 99.95% 否
HY-B0501 Danofloxacin mesylate Inhibitor 99.87% 否
HY-N7120 Penicillin G procaine hydrate Inhibitor 99.52% 否
HY-A0064R Verapamil hydrochloride (Standard) 99.81% 否
HY-14794A Levomilnacipran / 否
HY-B0777R Moxidectin (Standard) Inhibitor / 否
Clinical Phase
生物活性分子 (17)
目录号 产品名 作用方式
纯度 Phase
HY-10550 Tariquidar Inhibitor 99.45% Phase 3
HY-15255 Zosuquidar Inhibitor 99.90% Phase 3
HY-50671 Zosuquidar trihydrochloride Inhibitor 99.50% Phase 3
HY-10550A Tariquidar methanesulfonate, hydrate Inhibitor 98.52% Phase 3
HY-17013A Dofequidar fumarate Inhibitor 98.0% Phase 3
HY-110377 Tariquidar dihydrochloride Inhibitor / Phase 3
HY-19642A Glesatinib hydrochloride Inhibitor 98.01% Phase 2
HY-14942 Berubicin 87.76% Phase 2
HY-106004 Zamicastat Inhibitor 99.93% Phase 2
HY-14942A Berubicin hydrochloride 95.08% Phase 2
HY-132189 Laniquidar Inhibitor 99.42% Phase 2
HY-19642 Glesatinib Inhibitor / Phase 2
HY-120464 PF-05212377 Inhibitor / Phase 2
HY-16773 Vedroprevir Inhibitor / Phase 2
HY-50879 Elacridar Inhibitor 99.94% Phase 1
HY-108286 Talinolol Antagonist 99.64% Phase 1
HY-17013D Dofequidar sesquifumarate Inhibitor / Phase 1
Pre-clinical Phase
生物活性分子 (151)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-10010 Ko 143 Inhibitor 99.97% 否
HY-N6684 Deoxynivalenol 99.39% 否
HY-N0069 Solamargine 99.86% 否
HY-50880 Elacridar hydrochloride Inhibitor 99.93% 否
HY-107643 Reversan Inhibitor 99.90% 否
HY-13925 PD0166285 99.46% 否
HY-N0217 Benzoylaconine 99.92% 否
HY-N3584 Paris saponin VII 99.96% 否
HY-108694 γ-Tocotrienol Inhibitor 99.73% 否
HY-N1916 Coniferyl ferulate 98.73% 否
HY-N3308 Medicarpin Inducer 99.06% 否
HY-N2453 Convallatoxin 99.72% 否
HY-W009141 1-Monopalmitin 95.0% 否
HY-100750 Norverapamil hydrochloride Inhibitor 99.80% 否
HY-161246 uPSEM792 Agonist 99.92% 否
HY-N1941 Isosinensetin Inhibitor 99.90% 否
HY-N2103 Tenacissoside G 99.64% 否
HY-119823 PGP-4008 Inhibitor 99.69% 否
HY-162753 ZW-1226 Inhibitor 98.13% 否
HY-N2416 Taccalonolide A 98.88% 否
HY-N6015 Bacopasaponin C Inhibitor 99.76% 否
HY-N6932 Voacamine 99.64% 否
HY-17013 Dofequidar Inhibitor 98.17% 否
HY-A0064S Verapamil-d3 hydrochloride 99.57% 否
HY-113805 MC70 Inhibitor 99.50% 否
HY-126940 Furanodiene 99.83% 否
HY-N1457 Chrysosplenetin 99.68% 否
HY-173162 GPV0057 99.20% 否
HY-P10856 CPI1 Inhibitor 98.34% 否
HY-W001601 Budipine Antagonist 99.41% 否
HY-N6748 Roquefortine C 98.42% 否
HY-119101 AZD-5672 95.74% 否
HY-132866 YS-370 Inhibitor 98.07% 否
HY-N3028 Taccalonolide B Inhibitor 99.46% 否
HY-RS00048 ABCB1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-16191 ELR510444 98.0% 否
HY-B0777S Moxidectin-d3 Inhibitor 95.71% 否
HY-101791 P-gp inhibitor 1 Inhibitor 98.79% 否
HY-19626 NSC23925 Inhibitor 99.43% 否
HY-143792 HTT-D3 Inhibitor / 否
HY-155391 hCA/Wnt/β-catenin-IN-1 Inhibitor 99.96% 否
HY-N4108 Hypophyllanthin Inhibitor 98.84% 否
HY-W035709 Hydrocinchonine 98.33% 否
HY-162373 α-Amylase/α-Glucosidase-IN-10 Inhibitor / 否
HY-112912 P-gp modulator 1 / 否
HY-130244 BACE1-IN-5 Inhibitor / 否
HY-10550B Tariquidar dimesylate Inhibitor / 否
HY-128685 FD 12-9 Inhibitor / 否
HY-146096 RMS3 / 否
HY-146097 RMS5 / 否
HY-149053 OY-101 Inhibitor / 否
HY-17367S2 Atazanavir-d9 / 否
HY-17367S3 Atazanavir-d5 / 否
HY-106753 Tolnapersine / 否
HY-108286S (Rac)-Talinolol-d5 Antagonist / 否
HY-116976 NSC-57969 / 否
HY-121247 Bromotetrandrine Inhibitor / 否
HY-123384 KR30031 Inhibitor / 否
HY-135328 Norverapamil Inhibitor / 否
HY-135328AS Norverapamil-d7 hydrochloride Antagonist 98.77% 否
HY-135328S Norverapamil-d7 Inhibitor / 否
HY-136589 Verapamil EP Impurity C hydrochloride Inhibitor 99.61% 否
HY-13925A PD0166285 dihydrochloride / 否
HY-14275S1 Verapamil-d7 / 否
HY-144366 P-gp inhibitor 3 Inhibitor / 否
HY-144393 P-gp/BCRP-IN-1 Inhibitor / 否
HY-144774 Topoisomerase I inhibitor 5 / 否
HY-146117 P-gp modulator 2 Modulator / 否
HY-146118 P-gp modulator 3 Modulator / 否
HY-146391 P-gp inhibitor 4 Modulator / 否
HY-147758 BACE1/2-IN-1 Inhibitor / 否
HY-14794AS Levomilnacipran-d10 hydrochloride / 否
HY-149053B (R)-OY-101 / 否
HY-149240 Anticancer agent 108 Inhibitor / 否
HY-149277 FM04 Inhibitor / 否
HY-149360 P-gb-IN-1 Inhibitor / 否
HY-149813 P-gp inhibitor 14 Inhibitor / 否
HY-149981 P-gp inhibitor 13 Inhibitor / 否
HY-150565 P-gp inhibitor 5 Inhibitor / 否
HY-152079 CYP1B1-IN-3 Inhibitor / 否
HY-155032 P-gp inhibitor 15 Inhibitor / 否
HY-157330 P-gp inhibitor 16 / 否
HY-157483 P-gp inhibitor 18 Inhibitor / 否
HY-157484 P-gp inhibitor 19 Inhibitor / 否
HY-157876 Anticancer agent 191 Inhibitor / 否
HY-158236 ORL1 antagonist 2 Antagonist / 否
HY-158435 P-gp inhibitor 23 Inhibitor / 否
HY-159085 P-gp inhibitor 24 Inhibitor / 否
HY-159935 Top1-IN-2 Inhibitor / 否
HY-161260 P-gp inhibitor 20 Inhibitor / 否
HY-161645 P-gp modulator-4 Modulator / 否
HY-161776 P-gp/CDK2-IN-1 Inhibitor / 否
HY-162040 P-gp inhibitor 17 Inhibitor / 否
HY-162369 PID-9 Inhibitor / 否
HY-162396 P-gp inhibitor 21 Inhibitor / 否
HY-162447 P-gp inhibitor 22 / 否
HY-162822 P-gp modulator-5 Modulator / 否
HY-163204 RhQ-DMB Inhibitor / 否
HY-165606 SB-T-1214 Inducer / 否
HY-168008 P-gp inhibitor 25 Inhibitor / 否
HY-168186 P-gp inhibitor 26 Inhibitor / 否
HY-168711 P-gp inhibitor 27 Inhibitor / 否
HY-168953 Lysosomal P-gp targeted agent 1 / 否
HY-171194 VU0530244 Antagonist / 否
HY-171195 VU0631019 Antagonist / 否
HY-172365 P7–2302 Inhibitor / 否
HY-172771 Multi-target kinase inhibitor 4 Inhibitor / 否
HY-173182 Antitumor agent-200 Inhibitor / 否
HY-173222 P-gp inhibitor 28 Inhibitor / 否
HY-173401 P-gp inhibitor 29 Inhibitor / 否
HY-17367S4 Atazanavir-d6 99.28% 否
HY-174223 α-Glucosidase-IN-90 Inhibitor / 否
HY-174324 VEGFR-2/P-gp-IN-1 / 否
HY-175206 P-gp-IN-30 Inhibitor / 否
HY-175522 P-gp-IN-31 / 否
HY-175838 P-gp-IN-32 Inhibitor / 否
HY-176193 P-gp modulator-7 Inhibitor / 否
HY-176287 ARN25657 / 否
HY-17648 MBL-II-141 Inhibitor / 否
HY-176557 NCI677397 / 否
HY-A0064S1 Verapamil-d6 hydrochloride / 否
HY-B0168BS Levomilnacipran-d5 hydrochloride / 否
HY-N144114 P-gp inhibitor 2 Inhibitor / 否
HY-N15636 Coccinine Inhibitor / 否
HY-RS10394 PGP Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10395 PGPEP1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W140488 1,2-Didecanoyl-sn-glycero-3-phosphoethanolamine / 否
HY-W286423 L-Pyroglutamic acid 7-amido-4-methylcoumarin Substrate / 否
HY-W700684 N-Didesmethyl Loperamide / 否
HY-W777317 Elacridar-d4(Major) / 否
HY-107197 8-Prenylchrysin Inhibitor / 否
HY-123934 VU6007477 Modulator / 否
HY-129698 MS-073 Inhibitor / 否
HY-141425 NSC73306 / 否
HY-14275S Verapamil-d3 / 否
HY-14275S2 Verapamil-d6 / 否
HY-169782 CJZ3 Inhibitor / 否
HY-17367S5 Atazanavir-d24 / 否
HY-N13157 11α-O-Benzoyl-12β-O-acetyltenacigenin B Inhibitor / 否
HY-N15297 Isotenulin Inhibitor / 否
HY-N7305 Jatrophane 5 Inhibitor / 否
HY-N7332 Pepluanin A Inhibitor / 否
HY-RS17045 Pgp Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23489 Pgp Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W035709R Hydrocinchonine (Standard) / 否
HY-W699430 Norverapamil-d6 hydrochloride Inhibitor / 否
HY-W705354 Vismodegib-d4 / 否
HY-W716916 Vismodegib-d7 / 否
HY-W854295 Phosphatidylinositol-1,2-dioctanoyl sodium Inhibitor / 否
HY-13646B Encequidar hydrochloride Inhibitor / 否
HY-U00247 MCI826 Agonist / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens PGP NCBI NCBI:283871
Mus musculus PGP NCBI NCBI:67078
Rattus norvegicus PGP NCBI NCBI:287115
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z